Johnson & Johnson Price to Sales Ratio 2006-2018 | JNJ
Historical PS ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current P/S ratio for Johnson & Johnson as of February 15, 2019 is .
| Johnson & Johnson P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2019-02-15 |
136.38 |
|
4.56 |
| 2018-12-31 |
129.05 |
$29.93 |
4.31 |
| 2018-09-30 |
138.17 |
$29.79 |
4.64 |
| 2018-06-30 |
121.34 |
$29.51 |
4.11 |
| 2018-03-31 |
127.21 |
$28.73 |
4.43 |
| 2017-12-31 |
137.82 |
$27.86 |
4.95 |
| 2017-09-30 |
127.46 |
$26.99 |
4.72 |
| 2017-06-30 |
128.88 |
$26.21 |
4.92 |
| 2017-03-31 |
120.54 |
$25.95 |
4.64 |
| 2016-12-31 |
110.78 |
$25.74 |
4.30 |
| 2016-09-30 |
112.81 |
$25.58 |
4.41 |
| 2016-06-30 |
115.07 |
$25.27 |
4.55 |
| 2016-03-31 |
101.91 |
$24.98 |
4.08 |
| 2015-12-31 |
96.06 |
$24.90 |
3.86 |
| 2015-09-30 |
86.66 |
$24.94 |
3.48 |
| 2015-06-30 |
89.78 |
$25.29 |
3.55 |
| 2015-03-31 |
91.99 |
$25.75 |
3.57 |
| 2014-12-31 |
94.96 |
$25.91 |
3.67 |
| 2014-09-30 |
96.17 |
$25.91 |
3.71 |
| 2014-06-30 |
93.76 |
$25.56 |
3.67 |
| 2014-03-31 |
87.43 |
$24.96 |
3.50 |
| 2013-12-31 |
80.93 |
$24.78 |
3.27 |
| 2013-09-30 |
76.08 |
$24.65 |
3.09 |
| 2013-06-30 |
74.79 |
$24.60 |
3.04 |
| 2013-03-31 |
70.48 |
$24.30 |
2.90 |
| 2012-12-31 |
60.12 |
$24.00 |
2.51 |
| 2012-09-30 |
58.59 |
$23.61 |
2.48 |
| 2012-06-30 |
56.93 |
$23.32 |
2.44 |
| 2012-03-31 |
55.04 |
$23.40 |
2.35 |
| 2011-12-31 |
54.25 |
$23.42 |
2.32 |
| 2011-09-30 |
52.20 |
$23.17 |
2.25 |
| 2011-06-30 |
54.04 |
$22.79 |
2.37 |
| 2011-03-31 |
47.72 |
$22.30 |
2.14 |
| 2010-12-31 |
49.37 |
$22.06 |
2.24 |
| 2010-09-30 |
49.03 |
$22.38 |
2.19 |
| 2010-06-30 |
46.30 |
$22.40 |
2.07 |
| 2010-03-31 |
50.65 |
$22.40 |
2.26 |
| 2009-12-31 |
49.65 |
$22.20 |
2.24 |
| 2009-09-30 |
46.57 |
$21.62 |
2.15 |
| 2009-06-30 |
43.10 |
$21.84 |
1.97 |
| 2009-03-31 |
39.56 |
$22.15 |
1.79 |
| 2008-12-31 |
44.62 |
$22.41 |
1.99 |
| 2008-09-30 |
51.27 |
$22.54 |
2.27 |
| 2008-06-30 |
47.31 |
$22.05 |
2.15 |
| 2008-03-31 |
47.36 |
$21.45 |
2.21 |
| 2007-12-31 |
48.38 |
$20.94 |
2.31 |
| 2007-09-30 |
47.36 |
$20.08 |
2.36 |
| 2007-06-30 |
44.12 |
$19.45 |
2.27 |
| 2007-03-31 |
42.87 |
$18.76 |
2.28 |
| 2006-12-31 |
46.70 |
$17.96 |
2.60 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$365.894B |
$81.581B |
|
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
|
